BeOne Medicines Unveils Breakthrough Hematology Data at EHA 2026, Redefining B-Cell Malignancy Treatment
Jun 12, 2026 19:00
CST Updated
Jun 13, 02:54
BeOne
Developer of Molecular Targeted and Immune Anti-Tumor Drugs